Synulox LC Plus Intramammary suspension for lactating cattle
Synulox LC Plus Intramammary suspension for lactating cattle
Authorised
- Prednisolone
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Synulox LC Plus Intramammary suspension for lactating cattle
Active substance:
- Prednisolone
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Cattle (dairy cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Prednisolone10.00/milligram(s)1.00Applicator
-
Potassium clavulanate59.60/milligram(s)1.00Applicator
-
Amoxicillin trihydrate229.60/milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow)
-
Meat and offal7day
-
Milk84hour84 hours. With cows milked twice daily, milk for human consumption may only be taken the 7th milking after the last treatment. Where any other milking routine is followed, milk may be taken for human consumption only after the same period from the last treatment (e.g. with 3 times a day milking, milk may be taken for human consumption at the 11th milking).
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID4) 900 gram(s): unspecified outer container with 300 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID3) 72 gram(s): unspecified outer container with 24 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID2) 36 gram(s): unspecified outer container with 12 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID1) 9 gram(s): Box (board) with 3 Applicator (low-density polyethylene) each with 3 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V512755
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0315/001
Concerned member states:
-
Belgium
-
Luxembourg
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 28/01/2026
2401895-paren-20181009.rtf
English (RTF)
Download Published on: 28/01/2026
